- Injective (INJ) dropped under a large rising triangle formation, which reassured a bearish change following several months of stalemate and unsuccessful upward motion.
- Resistance has been identified by analysts as at 14.50 and support as at 11.50 because the market has consistently been rejected many times, thus showing a loss of the bullish grip in the market.
- Technical estimates show that there will be a possible shift to $9, as it will be in support areas and will be further sold in the short term
Injective (INJ) has entered into a bear trend after falling below a crucial ascending triangle pattern that was built from March 2025. The decline is a strong signal of a momentum reversal, and investors are now awaiting $9 as the next support level.
Breakdown from Ascending Triangle Confirms Bearish Momentum
According to market analyst Ali_charts, Injective has invalidated its earlier bullish setup by breaking down below a significant rising trendline. The upward triangle with higher lows and horizontal resistance at $16.50 couldn’t sustain the momentum higher. This firm breakdown below the formation indicates waning buyer sentiment and mounting selling pressure.
Following the breakdown, INJ attempted a short-lived rebound toward the $13.50–$14 zone. However, the move was firmly rejected, reinforcing the newly established resistance area. The rejection confirmed a classic technical pattern—former support has flipped into resistance, a key signal of a bearish reversal.
The current trading structure places INJ below the cloud-like indicator region on the chart. This positioning suggests that bullish control has faded, and sellers are now dictating price direction. The pattern breakdown has shifted sentiment toward continued downside potential in the near term.
Price Rejection Reinforces Resistance Between $13.50 and $14.50
After the failed bounce, Injective continues to trade below its 2-year descending trendline. Technical analyst Quantum Ascend observed that the resistance level is still between 14.50 and 16.00 and the local support is in the range of 11.50. These zones are now guiding short-term market expectations.
The firm rejection at the $13.50–$14 range illustrates how previously strong support has turned into a defensive ceiling. Each recovery attempt has met selling pressure, preventing the token from regaining key momentum levels.
Unless INJ reclaims and holds above $14 soon, market sentiment is expected to favor sellers. The inability to close above this threshold has strengthened bearish conviction among short-term traders.
Technical Outlook Points Toward $9 as Next Support Zone
With INJ maintaining lower highs and trading below structural support, the chart setup signals a continuation of downward movement. The dotted projection outlined by analysts points toward $9, aligning with a prior support zone from early 2025.
This target aligns with the lower boundary of INJ’s consolidation range, where buyers previously emerged. However, without a recovery above $14, the probability of revisiting that level remains elevated.
Market participants are closely monitoring whether Injective can establish stability above near-term supports. Until that occurs, the broader outlook remains bearish, with $9 positioned as the next technical area of interest.
